What is PT Darya-Varia Laboratoria Tbk Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. PT Darya-Varia Laboratoria Tbk's annualized net income for the quarter that ended in Mar. 2024 was Rp269,956 Mil. PT Darya-Varia Laboratoria Tbk's average shareholder tangible equity for the quarter that ended in Mar. 2024 was Rp1,374,078 Mil. Therefore, PT Darya-Varia Laboratoria Tbk's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 19.65%.
The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Return-on-Tangible-Equity or its related term are showing as below:
ISX:DVLA'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.94 Med: 11.89 Max: 17.91
Current: 11.1
During the past 13 years, PT Darya-Varia Laboratoria Tbk's highest Return-on-Tangible-Equity was 17.91%. The lowest was 8.94%. And the median was 11.89%.
ISX:DVLA's Return-on-Tangible-Equity is ranked better than 63.38% of 934
companies
in the Drug Manufacturers industry
Industry Median: 6.265
vs ISX:DVLA: 11.10
PT Darya-Varia Laboratoria Tbk Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PT Darya-Varia Laboratoria Tbk's Return-on-Tangible-Equity
For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Darya-Varia Laboratoria Tbk's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
PT Darya-Varia Laboratoria Tbk Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of PT Darya-Varia Laboratoria Tbk's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Business Description
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, medical and dental equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics; wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory equipment, cosmetic; wholesale trade in pharmaceuticals; laboratory testing services, health support service activities, research and development, periodic inspection services, and many more activities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISX:DVLA has been successfully added to your 